GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B1281 SB-334867 hydrochlorideSummary: Orexin-1 receptor antagonist -
B1044 TCS 1102Summary: Antagonist for OX2 and OX1 receptors -
B1149 GSK962040Summary: Motilin receptor agonist -
B1137 GSK962040 hydrochlorideSummary: Small molecule, selective motilin receptor agonist -
B2167 MRS 2578Summary: P2Y6 receptor antagonist,potent and selective -
B2265 BRL-15572Summary: 5-HT1D receptor antagonist -
B1324 CGS 21680 HClSummary: A2 adenosine receptor agonist -
B2245 BRL-54443Summary: 5-HT1E/1F receptor agonist,potent and selective -
B1426 Org 27569Target: CB1 ReceptorsSummary: Cannabinoid CB1 receptor allosteric modulator -
B1792 Montelukast SodiumSummary: Leukotriene receptor antagonist
